DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Long A, Rahmaoui A, Rothman KJ, Guinan E, Eisner M, Bradley MS, Iribarren C, Chen H, Carrigan G, Rosén K, Szefler SJ.
Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab.
J Allergy Clin Immunol 2014;
134: 560-567
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.